2024-03-29T08:53:03Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_82EA43119A1E
2024-03-23T02:37:13Z
serval:BIB_82EA43119A1E
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.
10.1080/2162402X.2017.1314425
28638744
000402926200021
Ehx
G.
author
Fransolet
G.
author
de Leval
L.
author
D'Hondt
S.
author
Lucas
S.
author
Hannon
M.
author
Delens
L.
author
Dubois
S.
author
Drion
P.
author
Beguin
Y.
author
Humblet-Baron
S.
author
Baron
F.
author
article
2017
2017
Oncoimmunology
2162-4011
2162-4011
journal
6
5
e1314425
Azacytidine
NOD-scid IL-2Rγnull
graft-vs.-host disease
graft-vs.-leukemia effect
regulatory T cells
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: epublish